Medical devices, healthcare technology and the business of care
510(k) clearance · K261400

Ambu aScope Gastro; Ambu aScope Gastro Large

Ambu A/S · Decision date Sep 16, 2026

MEDTECHLEDGER EXPLANATIONK261400

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on September 16, 2026 for K261400, a traditional 510(k) submitted by Ambu A/S of Ballerup, Denmark, covering the Ambu® aScope™ Gastro and Ambu® aScope™ Gastro Large. The device falls under 21 CFR 876.1500 (Endoscope And Accessories), Class II, with classification product code FDS and subsequent product code FAM, in the Gastroenterology/Urology panel. Substantial equivalence is a marketing clearance, not premarket approval.

The FDA letter is addressed to Ambu, Inc. in Columbia, Maryland, care of correspondent Sanjay Parikh, and states the agency reviewed the notification against legally marketed predicate devices. The public record does not describe the specific components, design changes or performance data supporting the clearance, and the indications for use appear only in an enclosure not included in the available text. No clinical or comparative performance conclusions can be drawn from these records.

The database entry lists a receipt date of April 29, 2026, while the letter cites a dated and received date of August 14, 2026; the discrepancy is unresolved in the source. The submission was not reviewed by a third party, is not a combination product, and no predetermined change control plan was authorized.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Gastroenterology, Urology
Decision date
Sep 16, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261400
Regulatory pathway
510(k) premarket notification
Applicant
Ambu A/S
Product code
FDS
Decision code
SESE
Decision date
Sep 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Gastroscope And Accessories, Flexible/Rigid.

Applicant
Ambu A/S
Product code
FDS
FDA device class
2

FDA decision timeline

  1. K261400 received

    Application receipt date recorded by FDA.

  2. K261400 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Ambu A/S

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Ballerup

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records